Progress and problems in screening for carcinoma of the prostate

Area of Science:

• Urology
• Oncology
• Medical Screening

Background:

• Prostate cancer is a leading cause of cancer death in American men.
• Early diagnosis is crucial for curable treatment, but current detection rates are low.
• Existing screening methods include prostate biopsy, serum acid phosphatase, digital rectal exam, and transrectal sonography.

Purpose of the Study:

• To critically review current prostate cancer screening tests.
• To assess the effectiveness and limitations of existing screening protocols.
• To determine the need for improved screening strategies and further research.

Main Methods:

• Review of published reports on prostate cancer screening tests.
• Critical analysis of the sensitivity and positive predictive value of common screening methods.
• Evaluation of the impact of screening on prostate cancer mortality.

Main Results:

• No study has definitively proven that routine prostate cancer screening reduces mortality.
• Current screening tests exhibit low positive predictive value and sensitivity, limiting their usefulness.
• The effectiveness of existing screening protocols remains unproven.

Conclusions:

• Routine screening for prostate cancer using current tests is considered investigational.
• New studies are required to establish the value of screening, incorporating control groups and benefit-risk assessments.
• Improved diagnostic accuracy and validated screening protocols are needed for effective early detection.